The process of bringing new therapeutic goods to market and to patients is all about partnerships – ARCS has collaborated closely with the TGA, the PEB and the PBAC, government departments and research networks in the development of two exciting Congress programs for 2010. Both programs are available here – read carefully before making your decisions - register NOW to take advantage of Earlybird and Group discounts.
Sydney 2013 – A fountain of knowledge
April 4th, 2013
With over 120 speakers across 46 sessions, the ARCS Congress provides a fountain of knowledge for those that attend.
This year ARCS is running a single large conference with seven to eight concurrent sessions for those Medical Affairs, Pharmacovigilance, Medical Information with Clinical Research, Regulatory Affairs, Quality/GMP and Soft Skills has already attracted over 800 industry professionals. This premier event will focus on clinical research (Australia and Asia), study coordinators and data managers, medical affairs, pharmacovigilance, quality/GMP, medical writing, medical information, management. These will appeal to those working on prescription (including biologicals) and OTC medicines and devices.
- 46 sessions
- over 120 speakers
- TGA representatives
Leadership Forum News
October 21st, 2012
The 2012 Clinical Research Governance and Leadership Conference (and AGM) on the 20 November 2012 Stamford North Ryde was a great success. We brought together a fantastic programme addressing two significant issues facing many of us in industry – Clinical Research Governance and Personal Effectiveness.
- Who stole my mojo - Gary Bertwistle
- Mythbusters: The real story of governance
- Four personal effectiveness sessions
Canberra Congress News
February 21st, 2012
ARCS Health Economics Conference
The ARCS HE education committee wishes to invite all interested parties working in the reimbursement of both medicines and devices to submit a speaking topic or program suggestion for the 2013 ARCS Reimbursement Conference currently planned for November 2013.
Click here for details.
A focus on ANZTPA, the vision and next steps for the transition
Update on multiple TGA reforms announced or pending
Packaging and Labelling changes in New Zealand.
A strong devices programme
A full GMP/quality programme.
Pharmacovigilance and Post-Market accountabilities from a Regulatory perspective.
Opportunity to meet with TGA colleagues, from various offices including Scientific Evaluation, Manufacturing Quality, Parliamentary and Strategic Support, Information Management, Product Review, Signal Investigation – Devices and Devices Authorisation.
Dr Rohan Hammett, National Manager, TGA
Dr Stewart Jessamine, Group Manager, Medsafe, NZ
Some of our keynote speakers were:
Tor Graberg, Chief Pharmaceutical Inspector, Medical Products Agency, Sweden
Michael Arnold, Global Business Process Head, Pfizer
And over 13 TGA speakers covering topics relevant to personnel involved in submissions to the department.
Other International Speakers included:
© Copyright 2013 ARCS Australia